MedScienceSwiss AG

MedScienceSwiss AG (MSS)

MSS develops Plan B to combat antibiotic-resistant bacteria

MSS is a start up with a novel research approach to combat the current high mortality rate due to nosocomial infections caused by resistant bacteria.

The inactivation of pathogenic bacteria is achieved by

Modulated high-energy electromagnetic fields in our devices.

This new therapy is based on the production of a germ-specific resonance in which the bacterial membrane is altered or damaged

MSS creates a database.

MedScienceSwiss AG has developed and internationally patented three different devices for therapy application.